(Q33745878)

29 July 2017

title

Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant (English)

1 reference

stem cell transplantation

29 July 2017

main subject

1 reference

inferred from title

author

Julie Teruya-Feldstein

4

object named as

Julie Teruya-Feldstein

0 references

Sergio Giralt

8

object named as

Sergio Giralt

1 reference

Marcel R.M. van den Brink

29 July 2017

11

object named as

Marcel R M van den Brink

1 reference

29 July 2017

Jenna D Goldberg

1

1 reference

29 July 2017

Joanne F Chou

2

1 reference

29 July 2017

Steven Horwitz

3

1 reference

29 July 2017

Juliet N Barker

5

1 reference

29 July 2017

Farid Boulad

6

1 reference

29 July 2017

Hugo Castro-Malaspina

7

1 reference

29 July 2017

Ann A Jakubowski

9

1 reference

29 July 2017

Guenther Koehne

10

1 reference

29 July 2017

James W Young

12

1 reference

29 July 2017

Zhigang Zhang

13

1 reference

29 July 2017

Esperanza B Papadopoulos

14

1 reference

29 July 2017

Miguel-Angel Perales

15

1 reference

29 July 2017

publication date

31 January 2012

1 reference

29 July 2017

1 reference

29 July 2017

volume

53

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

1124-1129

1 reference

A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Defining the intensity of conditioning regimens: working definitions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Graft-versus-lymphoma effect in refractory cutaneous T-cell lymphoma after reduced-intensity HLA-matched sibling allogeneic stem cell transplantation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.

21 June 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.645818

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.645818

Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.645818

Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.645818

Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.645818

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.645818

Impact of high-dose chemotherapy on peripheral T-cell lymphomas

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054938

Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma

30 October 2018

1 reference

12 December 2020

Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay

1 reference

12 December 2020

T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease

1 reference

12 December 2020

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect

1 reference

12 December 2020

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

1 reference

12 December 2020

IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade

1 reference

12 December 2020

10.3109/10428194.2011.645818

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference